Log In
Print
BCIQ
Print
Print this Print this
 

Bosulif, bosutinib (PF-05208763, PF-5208763, SKI-606)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionDual inhibitor of BCR-ABL and Src kinase
Molecular Target BCR-ABL tyrosine kinase ; Src
Mechanism of ActionSrc inhibitor; BCR-ABL tyrosine kinase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today